← Eichor
Study identifier: NCT05556928 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

Condition: Multiple Myeloma · Amyloidosis · Plasma Cell Leukemia  ·  Sponsor: University of Alabama at Birmingham

PhaseN/A
Planned participants5000
Who can joinAll sexes, 50 Years to no upper limit
Healthy volunteersNo

About this study

The primary purpose of this protocol is to create a registry of older (≥50 years old) patients with Hematologic Malignancies. Our main objectives include: To understand the prevalence of frailty and geriatric impairments among patients aged ≥50y and above diagnosed with a hematologic malignancy at UAB and to gather information that would lend support for future research in this vulnerable population.

This description comes directly from the study's public registry record.

Talk to the study team

Landon Martin, BS  ·  (205) 638-2120  ·  landoncmartin@uabmc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Kirklin Clinic of UAB HospitalBirmingham, Alabama, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05556928